Literature DB >> 15003958

Obesity and the risk of Parkinson's disease.

Honglei Chen1, Shumin M Zhang, Michael A Schwarzschild, Miguel A Hernán, Walter C Willett, Alberto Ascherio.   

Abstract

Dopamine is involved in the regulation of food intake, and obese persons have decreased dopamine D2 receptor availability in the striatum. Furthermore, midlife triceps skinfold thickness has been found to be positively associated with the risk of Parkinson's disease (PD) among Japanese-American men in Hawaii. The authors prospectively investigated whether obesity was associated with PD risk in two large cohorts of US men and women. They documented 249 cases of PD in men (1986-2000) and 202 cases in women (1976-1998). Neither baseline body mass index (weight (kg)/height (m)(2)) nor early adult body mass index was associated with PD risk. The multivariate relative risk for a baseline body mass index of > or = 30 versus <23 was 0.8 (95% confidence interval (CI): 0.6, 1.2; p for trend = 0.3). Overall, waist circumference and waist-to-hip ratio were not related to PD risk. However, among never smokers, both variables showed significantly positive associations with PD risk. The relative risks for comparisons of extreme quintiles were 1.9 (95% CI: 1.0, 3.4; p for trend = 0.03) for waist circumference and 2.0 (95% CI: 1.1, 3.6; p for trend = 0.03) for waist-to-hip ratio. The results do not support a role of overall obesity in PD pathogenesis; however, central obesity may be associated with higher PD risk among never smokers, and this finding merits further investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15003958     DOI: 10.1093/aje/kwh059

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  29 in total

1.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

2.  Obesity, diabetes, and risk of Parkinson's disease.

Authors:  Natalia Palacios; Xiang Gao; Marjorie L McCullough; Eric J Jacobs; Alpa V Patel; Tinisha Mayo; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2011-07-07       Impact factor: 10.338

3.  Reply to: Diabetes and risk of Parkinson's disease.

Authors:  Natalia Palacios; Alberto Ascherio
Journal:  Mov Disord       Date:  2013-02       Impact factor: 10.338

4.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

5.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

6.  Mendelian randomization of serum urate and parkinson disease progression.

Authors:  Kelly Claire Simon; Shirley Eberly; Xiang Gao; David Oakes; Caroline M Tanner; Ira Shoulson; Stanley Fahn; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2014-10-03       Impact factor: 10.422

7.  Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.

Authors:  Samay Jain; Jayandra Himali; Alexa Beiser; Thanh G N Ton; Margaret Kelly-Hayes; Mary Lou Biggs; Joseph A C Delaney; Caterina Rosano; Sudha Seshadri; Samuel A Frank
Journal:  Am J Epidemiol       Date:  2014-12-29       Impact factor: 4.897

8.  Metabolic markers or conditions preceding Parkinson's disease: a case-control study.

Authors:  Rodolfo Savica; Brandon R Grossardt; J Eric Ahlskog; Walter A Rocca
Journal:  Mov Disord       Date:  2012-06-01       Impact factor: 10.338

9.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Obesity and restless legs syndrome in men and women.

Authors:  Xiang Gao; Michael A Schwarzschild; Hao Wang; Alberto Ascherio
Journal:  Neurology       Date:  2009-04-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.